Cancer Therapy Due to Apoptosis: Galectin-9.

Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T

Open source

DOI
10.3390/ijms18010074
Published
2017 Jan 1
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms18010074,
  title = {Cancer Therapy Due to Apoptosis: Galectin-9.},
  author = {Fujita K and Iwama H and Oura K and Tadokoro T and Samukawa E and Sakamoto T and Nomura T and Tani J and Yoneyama H and Morishita A and Himoto T and Hirashima M and Masaki T},
  year = {2017},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms18010074},
  url = {https://doi.org/10.3390/ijms18010074}
}

RIS

TY  - JOUR
TI  - Cancer Therapy Due to Apoptosis: Galectin-9.
AU  - Fujita K
AU  - Iwama H
AU  - Oura K
AU  - Tadokoro T
AU  - Samukawa E
AU  - Sakamoto T
AU  - Nomura T
AU  - Tani J
AU  - Yoneyama H
AU  - Morishita A
AU  - Himoto T
AU  - Hirashima M
AU  - Masaki T
PY  - 2017
JO  - International journal of molecular sciences
DO  - 10.3390/ijms18010074
UR  - https://doi.org/10.3390/ijms18010074
ER  - 

APA

K, F., H, I., K, O., T, T., E, S., T, S., T, N., J, T., H, Y., A, M., T, H., M, H., & T, M. (2017). Cancer Therapy Due to Apoptosis: Galectin-9.. International journal of molecular sciences. https://doi.org/10.3390/ijms18010074

Source records